4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[6-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]-3-cyclohexen-1-yl]methyl]hexahydro-, [2(cis),3aα,4β,7β,7aα]
- CAS139506-03-9
- CatalogueRS-D128038
- FormulaC28H34N4O2S
- MW490.67
On this page
structure on request
Product identification
| Product name | 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[6-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]-3-cyclohexen-1-yl]methyl]hexahydro-, [2(cis),3aα,4β,7β,7aα] |
|---|---|
| Catalogue No. | RS-D128038 |
| CAS No. | 139506-03-9 |
| Molecular formula | C28H34N4O2S |
| Molecular weight | 490.67 |
| Exact mass | 490.2402 (monoisotopic) |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Drug Metabolite Standards |
| Drug substance | Lurasidone |
| Also known as | Lurasidone Impurity 65 |
| Storage | 2-8°C Refrigerator |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-D128038 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Lurasidone
- Drug Metabolite Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-D128038
- Request a quotation for RS-D128038
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Lurasidone
All 88 further standards are listed here — every link is in the page, not loaded later.
Lurasidone
IN STOCKRS-I017018Lurasidone
IN STOCKRS-Z412MA6Lurasidone(Hydrochloride)
IN STOCKRS-P099002Lurasidone Impurity A
IN STOCKRS-L047033((1R,2R)-Cyclohex-4-ene-1,2-diyl)dimethanol
IN STOCKRS-D117051(1R,2R)-cyclohexane-1,2-dicarboxylic acid
IN STOCKRS-C031017(1R,2R)-dimethyl cyclohexane-1,2-dicarboxylate
IN STOCKRS-C031016(1R,2R,6S,7S)-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
IN STOCKRS-L047029(1S, 2R)-2-Carbamoyl-cyclohexanecarboxylic acid
BACK ORDERRS-U009A0F(3aR,4S,7S,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
IN STOCKRS-U074123(3aS,7aS)-octahydroisobenzofuran
IN STOCKRS-I004131(5aR,9aR)-Octahydrobenzo[e][1,3,2]dioxathiepine 3-oxide
IN STOCKRS-L047013(Chloromethyl)cyclohexane(mix)
IN STOCKRS-Z004UGG(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane
IN STOCKRS-C031012(R,R)-Cyclohex-4-ene-1,2-dicarboxylic Acid
IN STOCKRS-U0930761,2-Benzisothiazolin-3-one
IN STOCKRS-L0470351,2-Cyclohexanedicarboxylic Anhydride, Cis Trans
IN STOCKRS-I0984345-Norbornene-2,3-dicarboximide
IN STOCKRS-P025139Carbic Anhydride
IN STOCKRS-U063102Chloromesyl chloride
IN STOCKRS-U065322cis-3,6-Endomethylene tetrahydrophthalic anhydride
IN STOCKRS-Z412SVBCis-Lurasidone Impurity
CUSTOM SYNTHESISRS-Z412NUQCyclohexane-1,2-diyldimethanol
CUSTOM SYNTHESISRS-U045224diethyl cyclohexane-1,2-dicarboxylate
IN STOCKRS-C002004Diethylcis-1,2-Cyclohexanedicarboxylate
IN STOCKRS-U077182Dimethyl (1S,2S)-cyclohexane-1,2-dicarboxylate
IN STOCKRS-U062758Dimethylcis-1,2,3,6-Tetrahydrophthalate
CUSTOM SYNTHESISRS-U062345Endo Lurasidone
IN STOCKRS-L047003endo-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
IN STOCKRS-Z412PORexo-2,3-Norbornanedicarboximide
IN STOCKRS-L047011Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
IN STOCKRS-P030245Lurasidone 2-Epimer Hydrochloride
BACK ORDERRS-P099010Lurasidone Trans (S,S) Mesylate
IN STOCKRS-L047023lurasidone-001-SS-Na
BACK ORDERRS-U072201Lurasidone-2H-oxireno
BACK ORDERRS-L047019Lurasidone-D8
BACK ORDERRS-I003062Noreximide
IN STOCKRS-L047042Racemic Trans-1,2-Cyclohexanedicarboxylic Acid
IN STOCKRS-Z412OQBtrans-1,4-Cyclohexanedimethanol
IN STOCKRS-Z407FVKtrans-2-(Chloromethyl)cyclohexanemethanol
IN STOCKRS-Z393JQELurasidone Impurity 2
CUSTOM SYNTHESISRS-I001B33Lurasidone Impurity 3
IN STOCKRS-L047010Lurasidone Impurity 3(Hydrochloride)
IN STOCKRS-L047020Lurasidone Impurity 11
IN STOCKRS-L047018Lurasidone Impurity 15
BACK ORDERRS-L047034Lurasidone Impurity 17
IN STOCKRS-Z401KF6Lurasidone Impurity 21
IN STOCKRS-L047024Lurasidone Impurity 25
CUSTOM SYNTHESISRS-L047016Lurasidone Impurity 26
IN STOCKRS-L047004Lurasidone Impurity 32
IN STOCKRS-L047044Lurasidone Impurity 33
BACK ORDERRS-I004021Lurasidone Impurity 36
IN STOCKRS-L047012Lurasidone Impurity 39
IN STOCKRS-L047043Lurasidone Impurity 42
BACK ORDERRS-L047017Lurasidone Impurity 43
BACK ORDERRS-L047002Lurasidone Impurity 44
BACK ORDERRS-L047001Lurasidone Impurity 54
IN STOCKRS-I011084Lurasidone Impurity 59
IN STOCKRS-L047007Lurasidone Impurity 59 HCl
BACK ORDERRS-I001APOLurasidone Impurity 75
BACK ORDERRS-I001577Lurasidone Hydrochloride Impurity 83
IN STOCKRS-Z412RT6Lurasidone Impurity 105
CUSTOM SYNTHESISRS-L047050Lurasidone Impurity 107
CUSTOM SYNTHESISRS-L047015Lurasidone Impurity 127
IN STOCKRS-L047027Lurasidone Impurity 128
IN STOCKRS-L047032Lurasidone Impurity 129
IN STOCKRS-L047038Lurasidone Impurity 130
IN STOCKRS-L047039Lurasidone Impurity 131
CUSTOM SYNTHESISRS-L047048Lurasidone Impurity 132
IN STOCKRS-L047009Lurasidone Impurity 133
BACK ORDERRS-L047021Lurasidone Impurity 134
IN STOCKRS-L047022Lurasidone Impurity 135
BACK ORDERRS-L047025Lurasidone Impurity 136
IN STOCKRS-L047026Lurasidone Impurity 137
IN STOCKRS-L047030Lurasidone Impurity 138
IN STOCKRS-L047031Lurasidone Impurity 139
IN STOCKRS-L047037Lurasidone Impurity 140
BACK ORDERRS-L047040Lurasidone Impurity 141
CUSTOM SYNTHESISRS-L047041Lurasidone Impurity 142
IN STOCKRS-L047045Lurasidone Impurity 191
IN STOCKRS-U004426Lurasidone Metabolite 14283 hydrochloride
BACK ORDERRS-Z412NFJLurasidone Metabolite 14326-d8
BACK ORDERRS-L047047
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.







![Chemical structure of (1R,2R,6S,7S)-4-azatricyclo[5.2.1.02,6]decane-3,5-dione](/structures/w4/RIVOBMOBWMOLDJ-UMRXKNAASA-N.webp?v=11)

![Chemical structure of (2-((4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methanamine](/structures/w4/ISNHCWHFMIPSEZ-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of (3aR,4R,7S,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylMethyl]cyclohexylMethyl}hexahydro-4,7-Methano-2H-isoindole-1,3-dione hydrochloride](/structures/w4/NEKCRUIRPWNMLK-UBMRPRFGSA-N.webp?v=11)




![Chemical structure of (5aR,9aR)-Octahydrobenzo[e][1,3,2]dioxathiepine 3-oxide](/structures/w4/ZCVIMNDSJRRGRK-YUMQZZPRSA-N.webp?v=11)






















![Chemical structure of N-(benzo[d]isothiazol-3-yl)-N-(2-(N-(((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)methyl)cyclohexyl)methyl)formamido)ethyl)formamide](/structures/w4/GPZKJCZBPGWWSP-CVTJIBDQSA-N.webp?v=11)

![Chemical structure of rel-(2R,2aS,5aR,6S)-Hexahydro-2,6-methanooxireno[f]isobenzofuran-3,5-dione](/structures/w4/UUWMOJSMSOVYSY-UIHVAESESA-N.webp?v=11)









































